Geoffrey Raker
Partner @ Tailwind Capital
Geoffrey Raker is a managing director at Tailwind Capital. He is a graduate of Brown University, and of the Harvard Business School.
- Total investments:
- 2
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Geoffrey Raker invests in
Stages Geoffrey Raker invests in
Countries Geoffrey Raker invests in
Investment Focus
Industry
- Health Care 2 (100%)
- Pharmaceutical 2 (100%)
- Biotechnology 1 (50%)
- Online Portals 1 (50%)
Stage
- Series A 1 (50%)
- Private Equity 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Longs Drug Stores
|
Longs Drugs Stores is an online pharmacy and health based website. | Private Equity | |
Nautilus Neurosciences
|
Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders.In the first half of 2010, Nautilus intends to launch a novel product, CAMBIA� (diclofenac potassium for oralsolution).Nautilus is backed by Tailwind Capital, a leading private equity firm that invests in health care, business services and media/communications companies. | Series A |
About Tailwind Capital
Tailwind focuses on growing middle market companies in the healthcare, business services, and media/communications sectors. They are actively investing their $775 million fund.
Tailwind Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Bruce Dressel
Operating Executive of Infrastructure Services
|
|||
Eash Sundaram
Operating Executive
|
|||
Andrew Mayer
Partner
|
|||
Douglas Karp
Managing Partner
|
|||
|
Geoffrey Raker
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Geoffrey Raker invest in?
Geoffrey Raker invests primarily in Health Care, Pharmaceutical and Biotechnology startups, most often at Series A and Private Equity stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
